CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for EZZ Life Science Holdings Ltd is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

EZZ Life Science Holdings Ltd
104 Derby Street
Phone: +61 280021376p:+61 280021376 SYDNEY, NSW  2075  Australia Ticker: EZZEZZ
Business Summary
EZZ Life Science Holdings Limited is an Australian genomic life science company. The Company’s principal activity is the formulation, production, marketing and sale of the EZZ branded health supplements to retailers and consumers domestically and internationally. It is also engaged in wholesale distribution of the EAORON branded skin care products to retailers in Australia and New Zealand and direct to consumer distribution via a company operated EAORON e-commerce store. The Company's segments include Brought in Lines and Company Owned products. The United States focused brand EZZDAY’s products include EZZDAY Debloat & Gas Relief Pro (Capsule), EZZDAY Vaginal Probiotics & pH Balance (Capsule), EZZDAY Triple Anti Solution (NAD+, Multi-Collagen & Resveratrol) (Gummy), and EZZDAY Colon Detox (Capsule). The EZZ-branded products include EZZ Hair Growth Spray Duo, Maximum Growth Bundle, EZZ Children's Eye Health , EZZ JTN Immunity Plus, among others.

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
YesYes-----

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
12/31/20246/30/2024Yes----

Industries
SIC Code Description
2833 Medicinal chemicals and botanical products
2099 Food preparations, not elsewhere classified
5999 Miscellaneous retail stores, not elsewhere classified
8731 Commercial physical and biological research

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
Non-Executive Chairman of the Board Glenn W.Cross 12/1/2021 12/1/2021
Chief Financial Officer Brent J.Goldman 7/31/2020 7/31/2020
Chief Operating Officer, Executive Director QizhouQin 9/1/2019 9/1/2019
3 additional Officers and Directors records available in full report.

General Information
Outstanding Shares: 47,173,200 (As of 12/31/2024)
Shareholders: 840
Stock Exchange: ASX


Copyright © 2025 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Friday, June 27, 2025